Sakai, Japan

Koichi Yokota

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1987-2007

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Koichi Yokota

Introduction

Koichi Yokota is an esteemed inventor based in Sakai, Japan, recognized for his significant contributions to the fields of pharmaceuticals and biotechnology. With a portfolio of three patents, Yokota has played a crucial role in developing innovative solutions to address various medical conditions.

Latest Patents

Among his latest patents, Yokota has introduced a novel azasugar derivative and a drug containing this derivative as the active ingredient. This drug is particularly beneficial for treating keratinocyte-proliferative diseases. Additionally, Yokota has developed a neuroprotective drug that consists of ethyl 2-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]pyrrol-1-yl acetate as its essential active ingredient. This neuroprotective drug is intended for the prevention and treatment of brain dysfunction caused by hypoxia, particularly in situations resulting from disturbances in cerebral circulation, such as cerebral hemorrhage or cerebral infarction.

Career Highlights

Throughout his career, Koichi Yokota has worked with notable companies, including Kanebo, Limited and Carna Biosciences, Inc. His expertise and innovative mindset have made him a valuable asset in these organizations, where he has contributed significantly to their research and development efforts.

Collaborations

Yokota has collaborated with esteemed professionals in his field, including his coworkers Keizo Ito and Noriko Yamamoto. These collaborations have fostered an environment of creativity and innovation, allowing for the successful development of groundbreaking medical solutions.

Conclusion

Koichi Yokota's work exemplifies the spirit of innovation and dedication to advancing medical science. His contributions, particularly in the area of neuroprotective drugs and treatments for keratinocyte-proliferative diseases, validate the importance of persistent research and development in addressing critical health issues. As an inventor, his patents not only illustrate his ingenuity but also signify the potential for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…